Faculté des Sciences
Faculté des Sciences

Mémoire, Partim A, COLLÉGIALITÉ

Sicim, Yasemin ULiège
Promotor(s) : Monbaliu, Jean-Christophe ULiège
Date of defense : 19-Jan-2021 • Permalink :
Title : Mémoire, Partim A, COLLÉGIALITÉ
Author : Sicim, Yasemin ULiège
Date of defense  : 19-Jan-2021
Advisor(s) : Monbaliu, Jean-Christophe ULiège
Committee's member(s) : Silva Brenes, Diana Vanessa ULiège
Cattoen, Martin ULiège
Karaghiosoff, Konstantin 
Language : English
Number of pages : 73
Keywords : [en] continuous flow
[en] organophosphorus chemistry
Discipline(s) : Physical, chemical, mathematical & earth Sciences > Chemistry
Institution(s) : Université de Liège, Liège, Belgique
Degree: Master en sciences chimiques, à finalité approfondie
Faculty: Master thesis of the Faculté des Sciences


[en] Cancer is one of the leading causes of death worldwide. Thus, the administration of the appropriate treatment is of crucial importance to guarantee the recovery of millions of people each year. Cyclophosphamide, mentioned on the WHO List of Essential Medicines, is a phosphorus-based chemotherapy drug frequently used in the treatment of a vast array of cancers. It targets the DNA of cancerous cells as an alkylating nitrogen mustard derivative. It is also an immunosuppressive agent for various disorders of the immune system. The classical strategies for the batch synthesis of cyclophosphamide involve two steps which feature significantly long reaction times, hazardous and highly sensitive derivatives such as a nitrogen mustard derivative. The numerous assets of continuous flow, such as safety improvements and enhancement of reaction efficiency, could offer an alternative to the actual laborious production of cyclophosphamide. Herein, we report the flow synthesis of a non-chlorinated and safer analog of cyclophosphamide, which could be directly translated to the production of cyclophosphamide itself. First, we focused on its batch synthesis to obtain the analog in high purity as a reference in order to generate spectral data of novel compounds. We assessed 3 pathways: the traditional synthesis through a non-cyclic intermediate, the synthesis through a cyclic intermediate, and lastly a one-pot synthesis. Only the first route led to the desired analog in high purity. Next, a flow setup was established for this classical pathway. Both steps were conducted and optimized separately. N-methylimidazole and acetonitrile were first employed as the base and the solvent, respectively, to allow homogenous conditions through the formation of an ionic liquid, a necessary condition to enable smooth operation in continuous flow. The reaction conditions were modulated to reach optimal conversion and selectivity, however, this appeared insufficient. Subsequently, a batch screening of a multitude of bases and solvents was performed and led to an unprecedented process involving tributylamine, acetonitrile, and 2-methyltetrahydrofuran, which ensured homogenous conditions. Finally, we sought to concatenate the two optimized steps and achieved the synthesis of the cyclophosphamide analog in high conversion (94-99%) and selectivity (82-84%) in a fully concatenated system. Two other strategies, namely a continuous flow synthesis through a cyclic intermediate and a continuous flow process relying on a P(III) derivative, were assessed as well but did not lead to satisfactory results.



Access s161778YaseminSicim.pdf
Description: -
Size: 2.88 MB
Format: Adobe PDF


  • Sicim, Yasemin ULiège Université de Liège > Master en sc. chimiques, à fin.


Committee's member(s)

  • Total number of views 10
  • Total number of downloads 0

All documents available on MatheO are protected by copyright and subject to the usual rules for fair use.
The University of Liège does not guarantee the scientific quality of these students' works or the accuracy of all the information they contain.